Top Markets
Coin of the day
Faeth Therapeutics, Inc. Faeth Therapeutics, Inc.

Faeth Therapeutics, Inc.

FTH
Rank in Stocks #26773
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on... Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]
Share Price
$28.27
Last synced: 2026-08-11
Market Cap
$37.93M
Change (1 day)
-1.07%
Change (1 year)
255.09%
Country
US
Trade Faeth Therapeutics, Inc. (FTH)

Category

Number of shares outstanding for Faeth Therapeutics, Inc. (FTH)
Number of shares outstanding as of August 2026: 0
According to Faeth Therapeutics, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Faeth Therapeutics, Inc. (FTH) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
253.90M -
US
62.19M -
NL
483.58M -
AU
396.00M -
US
- -
CH